Oracle’s AI Agent Launch Fails to Lift a Stock Sinking Under a $42 Billion Cash Flow Deficit
Published on 07/14/2026 at 18:26 | Redaktion boerse-global.de
Oracle rolled out a new suite of AI-powered development tools on Tuesday, but Wall Street had other things on its mind. The stock touched a fresh 52-week low of €111.58 and closed at €112.84, a daily loss of 2.59%. The announcement of a native AI agent platform inside Oracle Fusion Cloud Applications — one that lets developers use tools like VS Code, OpenAI Codex and Claude Code — was all but drowned out by a much louder sell-off.
The numbers tell a brutal story. The shares have shed roughly a third of their value in the past month and stand nearly 60% below the September 2025 high of €280.70. The relative strength index has dropped to 25.7–26.1, deep in oversold territory, and the annualized volatility sits at a jittery 48.35%. Technically, the stock is screaming "bounce," but the fundamental picture is far less clear.
Investors are fixated on a single tension: whether Oracle can convert its record backlog of $638 billion in remaining performance obligations (RPO) into cash fast enough to justify the debt piling up behind its AI infrastructure buildout. That backlog is heavily concentrated — OpenAI alone accounts for roughly half of the unfulfilled commitments, a dependency that prompted S&P Global to cut Oracle’s credit rating to BBB- earlier this month. The rating agency cited exactly this concentration risk.
The spending plan is staggering. Oracle has guided for net capital expenditures of $70 billion in the current fiscal year, with some analysts putting the upper boundary as high as $95 billion. To fund the expansion, the company intends to raise an additional $40 billion through a mix of debt and equity — including a $20 billion equity offering that keeps dilution fears alive. The free cash flow deficit has already ballooned to $23.7 billion, a staggering leap from last year’s $394 million shortfall. Unlike deep-pocketed tech rivals, Oracle lacks the fat operating cash flows to self-fund such ambitions.
Should investors sell immediately? Or is it worth buying Oracle?
Still, the bulls argue that the market is pricing in a worst case that fundamentals don't yet warrant. William Blair added Oracle to its top-pick list right in the middle of the current weakness — a timing that suggests at least some analysts see the sell-off as disconnected from demand trends. The average analyst price target stands at €219.87, implying a potential upside of roughly 95% from the current level. Across the Atlantic, a separate survey put the mean target at $268.27 as of mid-July, with President Capital cutting its target from $360 to $300 but maintaining an "Overweight" rating.
The bull case rests on the belief that the backlog will begin converting more quickly. Management expects to recognize 12% of those $638 billion in RPO over the next twelve months and another 34% within 13 to 36 months. If that pace accelerates, the stock could find a floor. The 50-day moving average at €156.99 offers a first upside target for any tactical recovery.
Yet the bears point to Melius Research, which warns that it is hard to gauge whether Oracle can stick to its investment plan if additional business from customers like OpenAI or Anthropic materializes. Competitors are unlikely to ease up — any pause in Oracle’s spending could hand market share to rivals. Meanwhile, the company’s own traditional software business is under pressure from the very AI tools Oracle wants to sell through its cloud.
Oracle at a turning point? This analysis reveals what investors need to know now.
The next clear test will come with the quarterly earnings report. Investors will be watching for updates on cloud revenue growth, the pace of cash flow improvement, and any signs that the $70 billion investment plan is translating into booked revenue. Until then, the gap between Oracle’s product offensive and its punishing share price remains wide open — and the RSI of 26 won’t be enough to close it on its own.
Ad
Oracle Stock: New Analysis - 14 July
Fresh Oracle information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
